Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 8

    1.

    Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.

    Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT.

    Diabetes Technol Ther. 2009 Nov;11(11):697-705.PMID: 19905885 [PubMed - in process]Related articles

    2.

    Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial.

    White NH, Quattrin T, St Aubin LB, Duggan WT, England RD, Fryburg JS.

    J Pediatr Endocrinol Metab. 2008 Jun;21(6):555-68.PMID: 18717242 [PubMed - indexed for MEDLINE]Related articles

    3.

    Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.

    Rosenstock J, Cefalu WT, Hollander PA, Belanger A, Eliaschewitz FG, Gross JL, Klioze SS, St Aubin LB, Foyt H, Ogawa M, Duggan WT.

    Diabetes Care. 2008 Sep;31(9):1723-8. Epub 2008 Jun 5.PMID: 18535196 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.

    Drummond MB, Schwartz PF, Duggan WT, Teeter JG, Riese RJ, Ahrens RC, Crapo RO, England RD, Macintyre NR, Jensen RL, Wise RA.

    Am J Respir Crit Care Med. 2008 Aug 1;178(3):225-32. Epub 2008 May 8.PMID: 18467511 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

    Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ; RADIANCE 2 Investigators.

    Lancet. 2007 Jul 14;370(9582):153-60.PMID: 17630038 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

    Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators.

    N Engl J Med. 2007 Apr 19;356(16):1620-30. Epub 2007 Mar 26.PMID: 17387131 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of torcetrapib on the progression of coronary atherosclerosis.

    Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM; ILLUSTRATE Investigators.

    N Engl J Med. 2007 Mar 29;356(13):1304-16. Epub 2007 Mar 26. Erratum in: N Engl J Med. 2007 Aug 23;357(8):835. Lasala, Gregory P [corrected to Lasala, Gabriel P]. PMID: 17387129 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Factors influencing the choice of hearing aids.

    DUGGAN WT.

    Calif Med. 1949 Mar;70(3):198-201.PMID: 18124248 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...